Aarti Pharmalabs Limited (APL) announced its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, following a Board meeting held on February 09, 2026. The company declared an interim dividend of ₹1.5 per equity share (@30%) for the financial year 2025-26, fixing February 16, 2026, as the record date for payment. For the quarter ended December 31, 2025, consolidated revenue from operations stood at ₹432 Crores, reflecting a 3.35% growth on a quarter-on-quarter (QoQ) basis compared to ₹418 Crores in the previous quarter. However, this represents a decrease of 19.70% year-on-year (YoY) from ₹538 Crores in the corresponding quarter of the previous year. Consolidated net profit for the quarter reached ₹48 Crores, showing a significant 71.43% increase QoQ from ₹28 Crores, but a 35.14% decline YoY from ₹74 Crores in December 2024.

Aarti Pharmalabs Limited is an established Indian manufacturer of Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, and Xanthine derivatives, serving a global clientele across the pharmaceutical and nutraceutical industries. The company operates six manufacturing units and three R&D centers, specializing in products like caffeine and oncology drugs. In recent updates from 2025, the company inaugurated the first phase of its greenfield manufacturing facility in Atali, Gujarat, featuring a 440 kL reactor capacity and 63 reactors. Furthermore, in 2025, APL achieved significant sustainability milestones, including an EcoVadis Gold Rating and approval of its greenhouse gas emission reduction targets by the Science Based Target initiative (SBTi). The company also bolstered its leadership in late 2025 and early 2026 with the appointments of Dr. Rakeshwar Bandichhor as Chief Scientific Officer and Shrihari S. Mane as Chief Technology Officer. While promoter holding stood at 43.10% as of December 2025, the company is backed by various institutional investors, including HDFC Multi Cap Fund and ICICI Prudential Expansion and Services Fund.